Assessing Erasca (ERAS) Valuation After Encouraging Early ERAS-0015 Data At JP Morgan Conference [Yahoo! Finance]
Erasca, Inc. (ERAS)
Company Research
Source: Yahoo! Finance
responses at low doses in the Phase 1 AURORAS-1 trial, with no dose-limiting toxicities reported. See our latest analysis for Erasca. The early ERAS-0015 data has lined up with a sharp swing in sentiment, with a 30-day share price return of 142.27% and a 1-year total shareholder return of 332.81% pointing to powerful momentum from a low base. If ERAS-0015 has caught your eye, this could be a good moment to see what else is moving in biotech and pharma using healthcare stocks With Erasca now trading near a three year high, a 1 year total shareholder return above 300% and the last close above some analyst targets, you have to ask yourself: is there still a buying opportunity here, or is the market already pricing in future growth? At a last close of US$8.31, Erasca is trading on a P/B of 6.8x, which puts a clear spotlight on what investors are paying for its equity today. P/B compares the company's market value to the book value of its net assets. This is a common way to thi
Show less
Read more
Impact Snapshot
Event Time:
ERAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ERAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ERAS alerts
High impacting Erasca, Inc. news events
Weekly update
A roundup of the hottest topics
ERAS
News
- Erasca (ERAS) Touches 3-Year High as 4 Analysts Go Bullish; Gets 267% PT Hike [Yahoo! Finance]Yahoo! Finance
- Erasca (NASDAQ:ERAS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.MarketBeat
- Erasca (ERAS) Climbs to 3-Year High as Analyst Hikes PT by 83% [Yahoo! Finance]Yahoo! Finance
- Erasca (ERAS) Is Up 60.7% After Early ERAS-0015 Data Highlights Pan-RAS Franchise Ambitions [Yahoo! Finance]Yahoo! Finance
- Erasca (ERAS) Hits Fresh High Anew as Firm Gets up to 267% PT Hike [Yahoo! Finance]Yahoo! Finance
ERAS
Earnings
- 11/12/25 - In-Line
ERAS
Sec Filings
- 1/15/26 - Form 144
- 1/14/26 - Form SCHEDULE
- 1/12/26 - Form 8-K
- ERAS's page on the SEC website